Dr. Witztum is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9434 Medical Center Dr
La Jolla, CA 92037Phone+1 619-543-6164Fax+1 619-543-3183- Is this information wrong?
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1969 - 1971
- Washington University in St. Louis School of MedicineClass of 1969
Certifications & Licensure
- CA State Medical License 1975 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1984
Publications & Presentations
PubMed
- 4 citationsVolanesorsen to Prevent Acute Pancreatitis in Hypertriglyceridemia.Alexander, V., Karwatowska-Prokopczuk, E., Prohaska, T., Li, L., Geary, R., Gouni-Berthold, I., Hegele, R., Stroes, E., Oral, E., Witztum, J., Tsimikas, S.> ;The New England Journal of Medicine. 2024 Feb 1
- Host-derived oxidized phospholipids initiate effector-triggered immunity fostering lethality upon microbial encounter.Poli, V., Tan, P., Spreafico, R., Chu, A., Gordts, P., Pandolfi, L., Meloni, F., Springstead, J., Zanoni, I., Gioia, M., Cuenca, A., Witztum, J., Chou, J.> ;Biorxiv. 2023 Nov 21
- 5 citationsOxidized phospholipids in cardiovascular disease.Sotirios Tsimikas, Joseph L Witztum> ;Nature Reviews. Cardiology. 2024 Mar 1
- Join now to see all
Press Mentions
- FDA-Rejected Tx for FCS Proves Mettle in Phase III TrialAugust 7th, 2019
- Antibodies Against Oxidized Phospholipids Protect Against OsteoporosisOctober 18th, 2018
- National Lipid Association Announces Recipients of 2018-19 Junior Faculty Research AwardsJune 7th, 2018
- Join now to see all
Grant Support
- Program Project: Role Of Innate Immunity In AtherosclerosisNational Heart, Lung, And Blood Institute2009–2012
- Role Of Innate Immune Mechanisms In AtherogenesisNational Heart, Lung, And Blood Institute2008–2012
- Administrative CoreNational Heart, Lung, And Blood Institute2008–2012
- Bridge D: Oxidize Lipids In MacrophagesNational Institute Of General Medical Sciences2008–2011
- Development Of A Vaccine Approach To Inhibit AtherosclerosisNational Heart, Lung, And Blood Institute2007–2011
- Evaluation Of Patients With HyperlipidemiaNational Center For Research Resources1995–2010
- Role Of Innate Immunity In AtherosclerosisNational Heart, Lung, And Blood Institute2008
- Bridge D: Oxidized Lipids In MacrophagesNational Institute Of General Medical Sciences2003–2007
- Core A-- ImmunologyNational Heart, Lung, And Blood Institute2004–2006
- Immune Responses To Oxldl And AtherosclerosisNational Heart, Lung, And Blood Institute2002–2006
- SCOR In Molecular Medicine And AtherosclerosisNational Heart, Lung, And Blood Institute1997–2006
- Gene Transfer Of Recombinant Antibody ProteinsNational Heart, Lung, And Blood Institute2001–2005
- Core D-- Administrative CoreNational Heart, Lung, And Blood Institute2004
- Role Of B-1 Lymphocytes In AthergenesisNational Heart, Lung, And Blood Institute2002–2004
- Anticardiolipin Antibodies And Oxidized PhospholipidsNational Heart, Lung, And Blood Institute1997–2004
- Core--ImmunologyNational Heart, Lung, And Blood Institute1997–2003
- Localization Of Antibodies To Oxidized LDL In Normal &Apoptotic CellsNational Center For Research Resources1998–2002
- Role Of B-1 Lymphocytes In AtherogenesisNational Heart, Lung, And Blood Institute2001
- B-Lymphocyte Mediated Immune Mechanisms In AtherogenesisNational Heart, Lung, And Blood Institute2000–2001
- Relationship Of Immunolgical Response To Modified LDL And AtherosclerosisNational Heart, Lung, And Blood Institute1997–2001
- Mk733 Zocor GEM StudyNational Center For Research Resources1998–1999
- Core--ImmunologyNational Heart, Lung, And Blood Institute1996–1997
- Consequences Of Postsecretory Modifications Of LipoproteinsNational Heart, Lung, And Blood Institute1996–1997
- Clinical Studies Of Lipoprotein MetabolismNational Heart, Lung, And Blood Institute1996–1997
- Apolipoprotein E Deficiency And AtherosclerosisNational Heart, Lung, And Blood Institute1990
Hospital Affiliations
- UC San Diego Medical Center - HillcrestSan Diego, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: